סימביקורט טורבוהלר 1604.5 מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 1604.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

סימביקורט טורבוהלר 3209  מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 3209 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

פורדיל כמוסות לשאיפה ישראל - עברית - Ministry of Health

פורדיל כמוסות לשאיפה

novartis israel ltd - formoterol fumarate dihydrate - אבקה לשאיפה - formoterol fumarate dihydrate 12 mcg - formoterol - formoterol - foradil is indicated in asthma ( including nocturnal asthma and exercise-induced symptoms) in those treated with inhaled corticosteroids who also require a long-acting beta agonist in accordance with current treatment guidelines.prophylaxis and treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd) including chronic bronchitis and emphysema.

סימביקורט טורבוהלר 804.5 מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 804.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

פוסטר 1006 ישראל - עברית - Ministry of Health

פוסטר 1006

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - תמיסה לשאיפה - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

דואו-רספ  ספירומקס  160 מקג 4.5 מקג ישראל - עברית - Ministry of Health

דואו-רספ ספירומקס 160 מקג 4.5 מקג

abic marketing ltd, israel - budesonide micronized; formoterol fumarate dihydrate - אבקה לשאיפה - formoterol fumarate dihydrate 4.5 mcg/dose; budesonide micronized 160 mcg/dose - formoterol and budesonide

דואו-רספ  ספירומקס  320 מקג 9 מקג ישראל - עברית - Ministry of Health

דואו-רספ ספירומקס 320 מקג 9 מקג

abic marketing ltd, israel - budesonide micronized; formoterol fumarate dihydrate - אבקה לשאיפה - formoterol fumarate dihydrate 9 mcg/dose; budesonide micronized 320 mcg/dose - formoterol and budesonide

פוסטר 2006 ישראל - עברית - Ministry of Health

פוסטר 2006

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - formoterol fumarate dihydrate 6 mcg/actuation; beclometasone dipropionate anhydrous 200 mcg/actuation - formoterol and beclometasone

טרימבו ישראל - עברית - Ministry of Health

טרימבו

kamada ltd, israel - beclometasone dipropionate; formoterol fumarate dihydrate; glycopyrronium as bromide - glycopyrronium as bromide 9 mcg/delivered dose; formoterol fumarate dihydrate 5.2 mcg/delivered dose; beclometasone dipropionate 87.4 mcg/delivered dose - formoterol, glycopyrronium bromide and beclometasone

סימביקורט ראפיהלר 1604.5 ישראל - עברית - Ministry of Health

סימביקורט ראפיהלר 1604.5

astrazeneca (israel) ltd - budesonide; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - formoterol fumarate dihydrate 4.5 mcg/actuation; budesonide 160 mcg/actuation - formoterol and budesonide